"Resistance" to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance

Journal of Virology - United States
doi 10.1128/jvi.01907-09
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Exosomes Packaging APOBEC3G Confer Human Immunodeficiency Virus Resistance to Recipient Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2008English

Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2006English

Characterization of Simian Immunodeficiency Virus SIVSM/Human Immunodeficiency Virus Type 2 VPX Function in Human Myeloid Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2008English

Human Immunodeficiency Virus (HIV)

2013English

Human Immunodeficiency Virus (HIV)

2018English

Human Immunodeficiency Virus (HIV)

Transfusion Science
1990English

Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy